Walleye Capital’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
42,300
+11,100
+36% +$239K ﹤0.01% 1954
2026
Q1
$358K Sell
31,200
-74,500
-70% -$1.05M ﹤0.01% 2930
2025
Q4
$1.52M Sell
105,700
-28,200
-21% -$488K ﹤0.01% 2090
2025
Q3
$2.53M Sell
133,900
-111,200
-45% -$1.83M 0.01% 1397
2025
Q2
$5.25M Buy
245,100
+227,500
+1,293% +$3.38M 0.02% 843
2025
Q1
$231K Sell
17,600
-17,400
-50% -$258K ﹤0.01% 3162
2024
Q4
$470K Sell
35,000
-22,500
-39% -$362K ﹤0.01% 3041
2024
Q3
$1.22M Sell
57,500
-63,400
-52% -$1.14M ﹤0.01% 2437
2024
Q2
$1.91M Buy
120,900
+108,500
+875% +$1.99M ﹤0.01% 2151
2024
Q1
$184K Buy
12,400
+2,400
+24% +$32.9K ﹤0.01% 4032
2023
Q4
$91.5K Hold
10,000
﹤0.01% 4077
2023
Q3
$55.7K Buy
+10,000
New +$70K ﹤0.01% 4162

Other funds holding OSCR

Walleye Capital's OSCR Position: Q2 2026 in Review

Walleye Capital increased its Oscar Health (OSCR) stake by 1,324% in Q2 2026, buying an estimated $16.3M and bringing the position to 814,974 shares worth $23.2M. The position accounts for 0.08% of the portfolio, ranked #212.

Walleye Capital first reported a position in OSCR in Q1 2022 and has held it in 12 quarters since. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Walleye Capital held 814,974 shares of Oscar Health worth $23.2M as of Q2 2026.
  • Walleye Capital bought 757,759 Oscar Health shares in Q2 2026, an estimated $16.3M.
  • Oscar Health made up 0.08% of Walleye Capital's portfolio in Q2 2026, its #212 holding.
  • Walleye Capital first reported a position in Oscar Health in Q1 2022 and has held it in 12 quarters since.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.